Home > Insider Trading > Filing (0001493152-24-039088)

Filing Details

Accession Number:: 0001493152-24-039088
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-10-01 21:58:10
Reporting Period:: 2024-09-26

Accepted Time:: 2024-10-01 21:58:10
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1641631	Beyond Air Inc.	XAIR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1602064	Robert Carey	C/O Beyond Air, Inc. 900 Stewart Avenue, Suite 301 Garden City NY 11530		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-09-26	1,476,626	$0.50	1,476,626	No	4	P	Indirect	The Carey 2020 Acelyrin Trust DTD 07/23/2020

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	The Carey 2020 Acelyrin Trust DTD 07/23/2020

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Pre-funded Warrants to purchase Common Stock	Acquisiton	2024-09-26	26,142	$0.00	26,142	$0.00
Common Stock	Pre-funded Warrants to purchase Common Stock	Acquisiton	2024-09-26	480,179	$0.00	480,179	$0.00
Common Stock	Warrants to purchase Common Stock	Acquisiton	2024-09-26	102,382	$0.00	102,382	$0.38
Common Stock	Warrants to purchase Common Stock	Acquisiton	2024-09-26	1,880,565	$0.00	1,880,565	$0.38
Common Stock	Warrants to purchase Common Stock	Acquisiton	2024-09-27	9,886,633	$0.00	9,886,633	$0.38

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
26,142	No	4	P	Indirect
480,179	No	4	P	Indirect
102,382	No	4	P	Indirect
1,880,565	No	4	P	Indirect
9,886,633	No	4	J	Indirect

Footnotes

Pursuant to a Securities Purchase Agreement (the "Agreement"), dated as of September 26, 2024, by and between Beyond Air, Inc. (the "Issuer") and Steven Lisi (the "Reporting Person"), the Reporting Person acquired in a private placement transaction 1,476,626 shares of common stock, $0.0001 par value per share (the "Common Stock"), pre-funded warrants to acquire 506,321 shares of Common Stock at an exercise price of $0.0001 per share, and common warrants to acquire 1,982,947 shares of Common Stock at an exercise price of $0.3793 per share.
The pre-funded warrants will be exercisable on or after the date on which the Company obtains stockholder approval (the "Initial Exercise Date"), as further described in the Agreement and in the Issuer's Current Report on Form 8-K filed with the SEC on September 27, 2024, and shall expire when exercised in full.
Each pre-funded warrant was purchased with an accompanying warrant for a purchase price of $0.5042 per pre-funded warrant and accompanying warrant.
The common warrants are exercisable on or after the Initial Exercise Date and will have a term that expires five years following the Initial Exercise Date.
Each common share was purchased with an accompanying warrant for a purchase price of $0.5043 per share and accompanying warrant.
Pursuant to a binding term sheet dated as of September 27, 2024, and in connection with a loan to the Issuer of $7,500,000, the Reporting Person acquired warrants to purchase up to 9,886,633 shares of Common Stock.
The warrants issuable will be exercisable on or after the Initial Exercise Date and will expire five years following such date they are exercisable.